380 related articles for article (PubMed ID: 17397493)
1. Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples.
Cunderlíková B; Wahlqvist R; Berner A; Vasovic V; Warloe T; Nesland JM; Peng Q
Cytopathology; 2007 Apr; 18(2):87-95. PubMed ID: 17397493
[TBL] [Abstract][Full Text] [Related]
2. Spectrophotometric photodynamic detection involving extracorporeal treatment with hexaminolevulinate for bladder cancer cells in voided urine.
Nakai Y; Ozawa T; Mizuno F; Onishi S; Owari T; Hori S; Morizawa Y; Tatsumi Y; Miyake M; Tanaka N; Tsuruta D; Fujimoto K
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2309-2316. PubMed ID: 28726046
[TBL] [Abstract][Full Text] [Related]
3. Biosensor device for the photo-specific detection of immuno-captured bladder cancer cells using hexaminolevulinate: An ex-vivo study.
Chan KM; Vasilev K; Shirazi HS; McNicholas K; Li J; Gleadle J; MacGregor M
Photodiagnosis Photodyn Ther; 2019 Dec; 28():238-247. PubMed ID: 31394301
[TBL] [Abstract][Full Text] [Related]
4. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.
Marti A; Jichlinski P; Lange N; Ballini JP; Guillou L; Leisinger HJ; Kucera P
J Urol; 2003 Aug; 170(2 Pt 1):428-32. PubMed ID: 12853792
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic approach for cancer cells in urine sediments by 5-aminolevulinic acid-based photodynamic detection in bladder cancer.
Miyake M; Nakai Y; Anai S; Tatsumi Y; Kuwada M; Onishi S; Chihara Y; Tanaka N; Hirao Y; Fujimoto K
Cancer Sci; 2014 May; 105(5):616-22. PubMed ID: 24602011
[TBL] [Abstract][Full Text] [Related]
6. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.
Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA
Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Advances in Urine Cytology.
Xing J; Reynolds JP
Surg Pathol Clin; 2018 Sep; 11(3):601-610. PubMed ID: 30190143
[TBL] [Abstract][Full Text] [Related]
9. A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation Study.
Davis N; Shtabsky A; Lew S; Rona R; Leibovitch I; Nativ O; Cohen M; Mor Y; Lindner U; Glickman Y; Matzkin H; Tsivian A; Gofrit O; Yossepovitch O
Eur Urol Focus; 2018 Apr; 4(3):388-394. PubMed ID: 28753799
[TBL] [Abstract][Full Text] [Related]
10. The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder.
Giella JG; Ring K; Olsson CA; Karp FS; Benson MC
J Urol; 1992 Aug; 148(2 Pt 1):293-6. PubMed ID: 1635121
[TBL] [Abstract][Full Text] [Related]
11. Improving hexaminolevulinate enabled cancer cell detection in liquid biopsy immunosensors.
Chan KM; Gleadle J; Li J; Michl TD; Vasilev K; MacGregor M
Sci Rep; 2021 Mar; 11(1):7283. PubMed ID: 33790357
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of perioperative methylene blue-stained and permanent Papanicolaou-stained urine cytology to detect patients with high-grade urothelial cancer or the urinary bladder. Part 1].
Rossi R; Jaeger T; Börgermann C; Furtkamp C; Moos Stahl R; Rübben H; vom Dorp F
Urologe A; 2007 Sep; 46(9):1145-7. PubMed ID: 17661004
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
[TBL] [Abstract][Full Text] [Related]
15. [Fluorescence cytology. Improvement of urinary cytology].
Tritschler S; Tauber S; Meier R; Stepp H; Karl A; Zaak D; Stief CG
Urologe A; 2007 Sep; 46(9):1121-3. PubMed ID: 17634912
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?
Buchumensky V; Klein A; Zemer R; Kessler OJ; Zimlichman S; Nissenkorn I
J Urol; 1998 Dec; 160(6 Pt 1):1971-4. PubMed ID: 9817302
[TBL] [Abstract][Full Text] [Related]
17. THE SIGNIFICANCE OF EPIDERMAL GROWTH FACTOR RECEPTOR AND SURVIVIN EXPRESSION IN BLADDER CANCER TISSUE AND URINE CYTOLOGY OF PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER.
Kehinde EO; Al-Maghrebi M; Anim JT; Kapila K; George SS; Al-Juwaiser A; Memon A
East Afr Med J; 2013 Jan; 90(1):19-27. PubMed ID: 26862626
[TBL] [Abstract][Full Text] [Related]
18. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I
Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193
[TBL] [Abstract][Full Text] [Related]
19. Protoporphyrin IX induced by 5-aminolevulinic acid in bladder cancer cells in voided urine can be extracorporeally quantified using a spectrophotometer.
Nakai Y; Anai S; Onishi S; Masaomi K; Tatsumi Y; Miyake M; Chihara Y; Tanaka N; Hirao Y; Fujimoto K
Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):282-8. PubMed ID: 25595357
[TBL] [Abstract][Full Text] [Related]
20. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.
Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ
J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
